BCOR-CCNB3 fusion–positive sarcoma treated with chemotherapy and carbon-ion radiotherapy: a case report of long-term disease control of a cervical spine case with a 12-year follow-up - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Management of BCOR-CCNB3 Fusion-Positive Sarcoma with Chemotherapy and Carbon-Ion Radiotherapy: A Case Study Highlighting Long-Term Disease Control in a Cervical Spine Patient Over 12 Years

  • By

  • Naoki Oike

  • Reiko Imai

  • Akira Ogose

  • Takashi Ariizumi

  • Yudai Murayama

  • Tomohiro Miyazaki

  • Kazunaga Kimura

  • Hajime Umezu

  • Hiroyuki Kawashima

  • June 10, 2026

Share

Original Source(s)

BCOR-CCNB3 fusion–positive sarcoma treated with chemotherapy and carbon-ion radiotherapy: a case report of long-term disease control of a cervical spine case with a 12-year follow-up

  • by Naoki Oike, Reiko Imai, Akira Ogose, Takashi Ariizumi, Yudai Murayama, Tomohiro Miyazaki, Kazunaga Kimura, Hajime Umezu, Hiroyuki Kawashima

  • June 10, 2026

Related Content

Correction: Serial ctDNA dynamics predict clinical outcomes in metastatic and locally advanced PDAC: a systematic review

Moving Cancer Survivorship Into Routine Care—Why Are We Still Not Ready for Change?

Correction: Surgical treatment and prognosis in patients with intestinal metastases originated from advanced epithelial ovarian cancer